NYC Plastic Surgeon, Dr. Nolan Karp, Now Offering FDA-Approved Natrelle® 410 Breast Implants

Dr. Nolan Karp of KCNY Plastic Surgery explains the patient-side benefits of these “gummy bear” breast implants.

Online PR News – 30-March-2013 – 3/27/2013, New York, NY – New York, NY Cohesive silicone gel breast implants - available overseas for well over a decade - have recently taken the United States by storm. With several manufacturers vying for clearance, Allergan has just announced FDA approval of its Natrelle 410 shaped implant. New York plastic surgeon Dr. Nolan Karp was on hand to discuss important patient-side benefits of this cutting-edge approach.

"For several years, the Natrelle 410 implant has been one of the top implant-types throughout Europe and Canada," reports Dr. Karp. "With its recent FDA approval, American women now have an important new option in the battle against a small or disproportionate bust line." Dr. Karp - who is known as one of New York's top breast surgeons - went on to describe the implant's unique design.

"Natrelle 410 implants are shaped with a woman's unique anatomy in mind," explains Dr. Karp. "Achieving a remarkably natural silhouette, they are an effective alternative to traditional round implants." Part of a category known as "gummy bear" implants, Dr. Karp went on to detail the advantages of highly cohesive gel.

"Cohesive silicone gel implants - colloquially referred to as 'gummy bears'-are known for their safety and their ability to hold their shape," explains Dr. Karp. "Allergan's Natrelle 410s are no exception to this."

Dr. Karp also went on to explain a few of the implant's most important patient-side benefits. "For the patient, the most important benefit is a consistent result over time," explains Dr. Karp. "The implant's tear-drop shape, coupled with its form-stable filler, ensures a natural-looking result for years and years to come." Dr. Karp's assertions confirm patient satisfaction data released by Allergan. According to the manufacturer, "The Natrelle® 410 has 96.5% satisfaction at 7 years in primary augmentation patients." Furthermore, the company reports "…no observed gel migration in ruptured implants through 7 years."

Asked to speak on the significance of Allergan's recent FDA approval, Dr. Karp finished with this: "With a track record of safety, efficacy and patient satisfaction, our practice is proud to be offering Natrelle® 410 implants. We are confident that more and more women will begin exploring this option in the coming months."

Dr. Karp offers plastic surgery consultations in New York City. Interested parties are encouraged to schedule an appointment at (212) 355-5779.

About Dr. Karp

Dr. Nolan Karp, a board-certified plastic surgeon in Manhattan, is highly respected and well-known. He has been featured in numerous publications and has been listed as a "Top Doctor" in plastic surgery by several magazines.

Board-certified by the American Board of Plastic Surgery, Dr. Karp graduated from Northwestern University School of Medicine in 1983. He completed his general surgery training at New York University School of Medicine. This was followed with plastic surgery training, research fellowship, and microsurgery fellowship training at the Institute of Reconstructive Plastic Surgery at New York University School of Medicine.

Dr. Karp joined the Faculty of the Institute and NYU in 1992. Last year, with Dr. Mihye Choi, he was the Course Director of the NYU sponsored meeting: Breast Reconstruction: State of the Art.

At his newly constructed office in midtown Manhattan, Dr. Karp practices at KCNY Plastic Surgery with Dr. Mihye Choi. KCNY can be reached at (212) 355-5779 or )

Contact mail: